Spineguard (XPAR:ALSGD) Short-Term Debt: €0.47 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Spineguard Short-Term Debt?

Spineguard XPAR:ALSGD -0.60% Short-Term Debt is €0.47 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Spineguard's Short-Term Debt for the quarter that ended in Dec. 2025 was €0.47 Mil.

Spineguard's quarterly Short-Term Debt declined from Dec. 2024 (€1.31 Mil) to Jun. 2025 (€1.23 Mil) and declined from Jun. 2025 (€1.23 Mil) to Dec. 2025 (€0.47 Mil).

Spineguard's annual Short-Term Debt increased from Dec. 2023 (€1.09 Mil) to Dec. 2024 (€1.31 Mil) but then declined from Dec. 2024 (€1.31 Mil) to Dec. 2025 (€0.47 Mil).

Spineguard Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Spineguard Short-Term Debt Related Terms

Spineguard Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Spineguard's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spineguard Short-Term Debt Chart

Spineguard Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.89 1.09 1.31 0.47

Spineguard Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 1.16 1.31 1.23 0.47
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €0.47 Mil mean?
Spineguard (XPAR:ALSGD) has a Short-Term Debt of €0.47 Mil as of Dec. 2025.
Is Spineguard's Short-Term Debt too high?
Spineguard's current Short-Term Debt is €0.47 Mil.
How does Spineguard's Short-Term Debt compare to ABT and SYK?
Spineguard's Short-Term Debt of €0.47 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Spineguard's current Short-Term Debt is €0.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spineguard stock overvalued right now?
Based on GuruFocus' analysis, Spineguard (XPAR:ALSGD) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.10, compared to a current price of €0.08 — trading 17% below its estimated fair value. The current Short-Term Debt is €0.47 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Spineguard (XPAR:ALSGD), the current Short-Term Debt is €0.47 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Spineguard Business Description

Other Exchanges 6W5:Germany
Address 10 Cours Louis Lumiere, Vincennes, FRA, 94300
Spineguard is engaged in the design and production of medical instruments used for spinal surgeries. It is deploying its proprietary radiation-free real time sensing technology DSG (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. It designs, develops and markets medical devices embedding its technology. The group is developing DSG digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and smart drills. SpineGuard is extending the applications of its DSG technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.